Real-Time Quote
 -0.22 / -0.32%
Today’s Change
Today|||52-Week Range
NPS Pharmaceuticals and Shire Up on Takeover Rumors - Analyst Blog
Dec 18 / Zacks.com
Mylan pays bonuses to ease 'spinversion'
Dec 10 / FT.com
'Mad Money' Lightning Round: GE Is a Good Stock With Good Yield
Dec 18 / TheStreet.com
AbbVie Reveals Phase II Data on Blood Cancer Drug at ASH (Revised) - Analyst Blog
Dec 10 / Zacks.com
Novartis Successfully Expands Signifor Label in the U.S. - Analyst Blog
Dec 17 / Zacks.com
Novartis (NVS) Presents Additional Data on Leukemia Drug - Analyst Blog
Dec 08 / Zacks.com
Why NPS Pharmaceuticals, Inc. Stock Lifted Off in Midday Trading
Dec 17 / MotleyFool.com
AbbVie Reveals Phase II Data on Blood Cancer Drug at ASH - Analyst Blog
Dec 08 / Zacks.com
Better Big Pharma Spinoff: Zoetis Inc. or AbbVie Inc.?
Dec 17 / MotleyFool.com
This Could Be the Next Big Pharma Buyout
Dec 08 / MotleyFool.com
Billionaires Are Loading Up On These 3 Stocks
Dec 16 / MotleyFool.com
Time to Buy This Dip in Gilead Sciences, Inc. Stock?
Dec 08 / MotleyFool.com
3 Healthcare Stocks to Watch in 2015
Dec 15 / MotleyFool.com
Should Big Pharma Buy Into the Medical Marijuana Industry?
Dec 06 / MotleyFool.com
Could the World's Top-Selling Drug Be Toppled?
Dec 15 / MotleyFool.com
3 Reasons Gilead Sciences Could Soar in 2015
Dec 06 / MotleyFool.com
Novartis AG and Amgen Inc. Take Aim at Johnson & Johnson
Dec 15 / MotleyFool.com
Roche to Acquire California-based Ariosa Diagnostics - Analyst Blog
Dec 05 / Zacks.com
Banks' losses raise spectre of renewed proprietary trading
Dec 14 / FT.com
Sanofi Buys Merck's Manufacturing Facility in Puerto Rico - Analyst Blog
Dec 05 / Zacks.com
Abbvie (ABBV) Upgraded From Hold to Buy
Dec 12 / TheStreet.com
Will MedTech Gain from Republican Promises? - Zacks Analyst Interviews
Dec 05 / Zacks.com
Investors warm to Shire's independence
Dec 11 / FT.com
Will MedTech Gain from Republican Promises? - Industry Outlook
Dec 05 / Zacks.com
Shire Updates on Pipeline at Research & Development Day - Analyst Blog
Dec 11 / Zacks.com
Gilead Sciences, Inc. Beats Another Threat
Dec 05 / MotleyFool.com
Why Gilead Sciences and AbbVie Care About This Tiny Company
Dec 11 / MotleyFool.com
Trading Activity
Dec 04 / StockTwits
Incyte (INCY) Gains on Positive Baricitinib Study Results - Analyst Blog
Dec 10 / Zacks.com
Billionaires are dumping these 3 stocks
Dec 02 / CNNMoney.com
Roche (RHHBY) Presents Positive Data on Haemophilia Drug - Analyst Blog
Dec 10 / Zacks.com
'Milestone' in fight against Aids as treatment outpaces infections
Nov 30 / FT.com

To view my watchlist

Not a member yet?

Sign up now for a free account

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2014 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2014. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2014 and/or its affiliates.